Central Nervous System Stimulants - Adverse effects
Research News and Information

Saturday, November 21, 2009

[Attention Deficit Hyperactivity Disorder (ADHD) and road traffic - special considerations for the treatment of adolescents with ADHD]

30 Aug 2009 Attention Deficit Hyperactivity Disorder (ADHD) is not only a childhood disorder but symptoms persist into adolescence and adulthood in approximately one third of the patients. Especially inattention and poor concentration impair driving performance ... Read more...

Caffeine's implications for women's health and survey of obstetrician-gynecologists' caffeine knowledge and assessment practices.

30 Aug 2009 OBJECTIVE: Caffeine has relevance for women's health and pregnancy, including significant associations with spontaneous abortion and low birth weight. According to scientific data, pregnant women and women of reproductive age should be advised to ... Read more...

Armodafinil.

30 Aug 2009 Armodafinil is the R-enantiomer of modafinil, a wake-promoting agent, that primarily affects areas of the brain involved in controlling wakefulness. Once-daily armodafinil was effective in improving wakefulness in adult patients with excessive ... Read more...

Latest indexed articles for 'Central Nervous System Stimulants - Adverse effects'

These are the very latest articles for this heading:

• 42-year-old male methamphetamine user with dysarthria and facial droop. 29 Sep 2009
• [Attention Deficit Hyperactivity Disorder (ADHD) and road traffic - special considerations for the treatment of adolescents with ADHD] 30 Aug 2009
• Caffeine's implications for women's health and survey of obstetrician-gynecologists' caffeine knowledge and assessment practices. 30 Aug 2009
• Armodafinil. 30 Aug 2009
• Are psychostimulants a treatment option in mania? 30 Aug 2009
• Caffeine expectancy: instrument development in the Rasch measurement framework. 30 Aug 2009
• Panic disorder and social anxiety disorder subtypes in a caffeine challenge test. 18 Aug 2009
• Stimulant use linked to sudden death in children without heart problems. 10 Aug 2009
• Relation between fractures and mortality: results from the Canadian Multicentre Osteoporosis Study. 2 Aug 2009
• Modafinil as a potential motion sickness countermeasure. 30 Jul 2009
• Hallucinations associated with modafinil treatment for narcolepsy. 30 Jul 2009
• Spectrum of electrocardiographic and angiographic coronary artery disease findings in patients with cocaine-associated myocardial infarction. 30 Jul 2009
• Adolescent with history of hypercholesterolemia and ADHD: evidence-based practice. 29 Jun 2009
• Chronic preexposure to methylphenidate cross-sensitizes methamphetamine in male Japanese quail. 29 Jun 2009
• Side effects of methylphenidate in childhood cancer survivors: a randomized placebo-controlled trial. 29 Jun 2009
• Cardiac safety of methylphenidate versus amphetamine salts in the treatment of ADHD. 29 Jun 2009
• "Hey, doc, is it OK for me to drink coffee?". 29 Jun 2009
• Cardiovascular effects of methylphenidate. 29 Jun 2009
• Is psychopharmacologic treatment associated with neuropsychological deficits in bipolar youth? 28 Jun 2009
• Modafinil for the treatment of cocaine dependence. 24 Jun 2009

See a longer list of these articles.

Technical information about 'Central Nervous System Stimulants'

Definition: A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here.

Registry Number: 0

Descriptor UI: D000697

Alternative terms: Central Nervous System Stimulants; Central Stimulants; Stimulants, Central; Analeptics; Analeptic Drugs; Drugs, Analeptic; Analeptic Agents; Agents, Analeptic;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D27.505.696.282; D27.505.954.427.220;

Online Note: use CENTRAL NERVOUS SYSTEM STIMULANTS to search ANALEPTICS 1966-94

History Note: 95; was ANALEPTICS 1963-94; CENTRAL NERVOUS SYSTEM STIMULANTS was see ANALEPTICS 1985-94

Technical Notes: GEN or unspecified; prefer specifics; consider also CENTRAL NERVOUS SYSTEM /drug eff & BRAIN /drug eff; DF: CNS STIMULANTS